Skip to content

RenovoRx, Inc.

RNXT

CIK 0001574094

← back to feed
Revenue (TTM)
$1.45M
+2,511.6% YoY Q1 May 2026
Net Income (TTM)
−$11.75M
−26.7% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.33
+20.0% YoY Q1 May 2026
Gross Margin
73.5%
Q1 May 2026
Operating Margin
-860.3%
Q1 May 2026
Net Margin
-811.3%
Q1 May 2026
Free Cash Flow (TTM)
−$12M
Q1 May 2026
Cash
$12.36M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
45.1M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings